[go: up one dir, main page]

GB1065716A - Tetracycline derivatives and process for their preparation - Google Patents

Tetracycline derivatives and process for their preparation

Info

Publication number
GB1065716A
GB1065716A GB733066A GB733066A GB1065716A GB 1065716 A GB1065716 A GB 1065716A GB 733066 A GB733066 A GB 733066A GB 733066 A GB733066 A GB 733066A GB 1065716 A GB1065716 A GB 1065716A
Authority
GB
United Kingdom
Prior art keywords
bond
compounds
formula
salts
hemiketal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB733066A
Inventor
Robert Keith Blackwood
Charles Robert Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, Charles Pfizer and Co Inc filed Critical Pfizer Inc
Publication of GB1065716A publication Critical patent/GB1065716A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to tetracycline compounds having the following formulae <FORM:1065716/C2/1> in which X is H or CH3, X1 is OH or X and X1 together are methylene, or X1 represents a second bond connecting C6 and C5a, X2 is H or OH, X being CH3 when the C6-C5a bond is a single bond and/or X2 is OH and Y is H or Cl; and Z is H, Cl or F, X being CH3 when the 6-5a bond is a single bond and Z is H, or Z is halogen when X and X1 are together methylene; and when X1 is OH, the compound III may be in its 4-6 hemiketal form. <FORM:1065716/C2/2> wherein X, X1, X2 and Y have the aforesaid meanings <FORM:1065716/C2/3> wherein Z is H, Cl or F, X is CH3 or H, X2 is OH or H, with the proviso that X is CH3 when Z is H or X2 is OH; Y is H or Cl. Also their salts. Compounds of formula (A) are produced by reacting a compound of formula <FORM:1065716/C2/4> in which X, X1, X2, Y and Z have the aforesaid meanings, the 6-5a bond being a single bond, or in which the Z is halo and X1 is an oxygen connected to the 6 and 12 positions in a hemiketal bond, with a hydrocarbon dicarboxylic acid haloimide, e.g. N-chlorosuccinimide and, if X1 in compound III is a bond in the 6-5a position, dehydrating the product in which X1 is OH or an oxygen connected to C6 and C4 in a hemiketal bond. Compounds of formula (B) are produced by reducing compounds of formula (A), e.g. with alkali metal hydrosulphite in aqueous alcohol. The salts may be pharmaceutically acceptable, e.g. the sodium, potassium, magnesium, calcium, aluminium, zinc, iron and magnesium; metal chelates salts with amines. Barium and strontium salts may be used in the isolation and purification of these compounds.
GB733066A 1964-04-16 1964-06-26 Tetracycline derivatives and process for their preparation Expired GB1065716A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36034564A 1964-04-16 1964-04-16
US36043564A 1964-04-16 1964-04-16

Publications (1)

Publication Number Publication Date
GB1065716A true GB1065716A (en) 1967-04-19

Family

ID=27000853

Family Applications (2)

Application Number Title Priority Date Filing Date
GB2663764A Expired GB1065715A (en) 1964-04-16 1964-06-24 Tetracycline derivatives
GB733066A Expired GB1065716A (en) 1964-04-16 1964-06-26 Tetracycline derivatives and process for their preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB2663764A Expired GB1065715A (en) 1964-04-16 1964-06-24 Tetracycline derivatives

Country Status (4)

Country Link
BE (1) BE650353A (en)
CH (2) CH462155A (en)
FR (1) FR4359M (en)
GB (2) GB1065715A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108276404A (en) * 2012-08-31 2018-07-13 四相制药公司 Tetracycline compounds
US10961190B2 (en) 2016-10-19 2021-03-30 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES315101A1 (en) * 1965-07-08 1966-01-01 Folch Vazquez Conrado Salts of Tetracycline Antibiotics
US7858601B2 (en) 2004-10-25 2010-12-28 Paratek Pharmaceuticals, Inc. 4-substituted tetracyclines and methods of use thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108276404A (en) * 2012-08-31 2018-07-13 四相制药公司 Tetracycline compounds
US10913712B2 (en) 2012-08-31 2021-02-09 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
US10961190B2 (en) 2016-10-19 2021-03-30 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline
US11578044B2 (en) 2016-10-19 2023-02-14 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline
US12269807B2 (en) 2016-10-19 2025-04-08 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline

Also Published As

Publication number Publication date
CH462149A (en) 1968-09-15
GB1065715A (en) 1967-04-19
BE650353A (en) 1965-01-11
CH462155A (en) 1968-09-15
FR4359M (en) 1966-08-22

Similar Documents

Publication Publication Date Title
GB1124837A (en) Substituted anilides
GB1065716A (en) Tetracycline derivatives and process for their preparation
GB735408A (en) Chlorotoloxy-ethyl sulphates
ES400452A1 (en) Plant growth regulant compositions containing 2-haloethanesulphinic acid compounds
GB663733A (en) Dimethylamino vitamin a and its conversion to vitamin a
ES430419A1 (en) Zeolite
GB1077114A (en) Process for the production of 7-amino-3-phenyl-coumarin compounds
GB571340A (en) Improvements in or relating to dicyandiamide salts and methods of preparing same
GB1316361A (en) 5h-dibenzazepines
GB1112909A (en) Ergoline derivatives
GB1059812A (en) Novel processes for the preparation of intermediates useful in the preparation of colchicine compounds, and the intermediates thus prepared
GB1046302A (en) Tetrazole derivatives
GB1070139A (en) Novel imidazothiazole derivatives and a process for preparation thereof
GB1474142A (en) Lactone
GB1107277A (en) Process of producing new tetracycline derivatives
GB1059815A (en) Novel intermediates useful in the synthesis of colchicine compounds, processes for their preparation, and the intermediates thus prepared
GB1069337A (en) Basically substituted bis-naphthalimides and their production
GB1114018A (en) Process for producing 4-hydroxycyclohexanecarboxylic acid and derivatives thereof
GB1093908A (en) New derivatives of glycyrrhetinic acid
GB949405A (en) Aluminium chelate compositions
GB669016A (en) N-benzhydryl-n-acyl-ureas and process for the manufacture of same
GB877556A (en) Purification of a vitamin a intermediate
GB1095214A (en) Novel basically substituted cyclic ketone carboxylic acid esters
GB1394384A (en) Substituted xanthone carboxylic acid compounds
GB633748A (en) Improvements in or relating to the production of a vitamin a intermediate